Bacolot, Irene .

HRN: 24-93-24  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/31/2025
06/21/2025
IV
500mg
Q24H
Complicated UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: